Clinical trial · Observational
Multicentre Retrospective Cohort Study of Palliative Care Pathways in Patients Who Died From Sarcoma
NCT07532668CI-TRIAL-00108452SARCOPALLcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this observational study is to describe palliative pathways in adult patients who died from their sarcoma. The main question it aims to answer is: How patients who died from sarcoma are followed by palliative team.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Sarcoma | Sarcoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- adult patients who died from sarcoma with >1 agressivness near the end of life criteria
- label
- adult patients who died from sarcoma with 0-1 agressivness near the end of life criteria
Primary outcomes (1)
- measure
- Palliative pathways of patients who died from sarcoma
- timeFrame
- From date of inclusion until the date of death from any cause, assessed up to 42 months
- description
- Palliative pathways will be described using the proportion of patients with each of the following component : * hospitalisation in a palliative care unit, * consultation with palliative care doctor, * mobile palliative care team advice We collect data on the first and last time of each kind of palliative follow up, we collect the number of day between the meeting and death For exemple: palliative care unit: first meeting 200 days before death and last meeting 80 days before death
Secondary outcomes (7)
- measure
- Treatment with chemotherapy in the last 14 days of life
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Oncology follow up in Centre Léon Bérard, or Institut Gustave Roussy, or Institut Curie * sarcoma histology confirmed * \>18 years at diagnosis * death between 01/01/2024 ans 31/12/2024 * death related to sarcoma Exclusion Criteria: * \>1 year between last follow up in Centre Léon Bérard, or Institut Gustave Roussy, or Institut Curie and death * patient opposed to the collect of data
References
Publications (0)
Data not yet available
No reference posted for this study.